Journal profile · Obstetrics & Gynecology
BREAST
ISSN 0960-9776 · eISSN 1532-3080 · Churchill Livingstone · ENGLAND · Bi-monthly · Founded 1992
BREAST: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.05; fully open access; APC about USD 3,200; median 111 days to acceptance (106 articles, last 24 months); community-reported acceptance: 12%; 767 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
BREAST is published by Churchill Livingstone and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Breast Lesions and Carcinomas and Cancer Treatment and Pharmacology, together about 40.7% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Affiliated with the Australasian Society for Breast Disease (ASBD), the European Society for Medical Oncology (ESMO), and the Hong Kong Breast Oncology Group (HKBOG).The Breast is a multidisciplinary open access journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages. The Editors welcome the submission of original research articles, systematic reviews, viewpoints/commentaries and debate articles, and correspondences on all areas of pre-malignant and malignant breast disease, including:• Epidemiology and prevention • Translational research, encompassing the use of new technologies, molecular biology, genetics and pathology • Screening, early diagnosis, follow-up and response assessment: use of imaging, nuclear medicine and other technologies • Medical oncology • Radiation oncology • Breast surgery • Psycho-oncology • Quality of life • Survivorship • Supportive care • Palliative and end-of-life care • Advocacy • Breast nursing • Breast units management and organization of breast care, including health economics.
From the journal's Aims & Scope
Research area (LetPub): Obstetrics & Gynecology
Editor-in-chief Christos SotiriouPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 10, France 8, Belgium 7, Italy 6, Netherlands 6 (63 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology24.2%
- Breast Lesions and CarcinomasMedicine9.8%
- Cancer Treatment and PharmacologyMedicine6.8%
- HER2/EGFR in Cancer ResearchMedicine6.4%
- Global Cancer Incidence and ScreeningMedicine6.4%
- Advanced Breast Cancer TherapiesMedicine6.3%
- Breast Implant and ReconstructionMedicine5.9%
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Obstetrics & Gynecology | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Obstetrics & Gynecology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Obstetrics & Gynecology | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.05LetPub ·
- Impact factor (publisher)
- 5.2Publisher website ·
- CiteScore 2026-06
- 12.6LetPub ·
- CiteScore (publisher)
- 12.6Publisher website ·
- SJR 2026-06
- 2.65LetPub ·
- SNIP 2026-06
- 2.84LetPub ·
- h-index
- 70LetPub ·
- h-index
- 129OpenAlex ·
- i10-index
- 2,745OpenAlex ·
- 2-year mean citedness
- 2.26OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 203LetPub ·
Articles by year OpenAlex count · 10,599 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 202 | 202 | 114 |
| 2025 | 767 | 767 | 888 |
| 2024 | 190 | 190 | 1,612 |
| 2023 | 666 | 666 | 1,989 |
| 2022 | 162 | 162 | 7,497 |
| 2021 | 524 | 524 | 4,400 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
111 daysMedian, submission to acceptance · P25–P75 69 days – 167 days
- Acceptance to online
- median 1 days (106 articles)
- Submission to online
- median 116 days
- Sample
- 106 articles with submission and acceptance dates (490 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 12%LetPub ·
- Submission to first decision
- 13 daysPublisher website ·
- First decision after review
- 55 daysPublisher website ·
- Submission to acceptance
- 89 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,200 / EUR 2,990 / GBP 2,560 / JPY 396,900 | — | — | |
| LetPub | USD 3,520 | Yes | — | |
| Publisher website | USD 4,260 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Required
Article types accepted15, with length limits
- case reportEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- commentaryEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- correspondenceEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- editorialEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- editorialsEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- letterEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- original research paperEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …main text ≤ 3,000 words
- original research papersOriginal Research Papers: Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regul…Length not stated
- regular paperEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- research paperEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- review articleEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …main text ≤ 5,000 words
- review articlesReview Articles: Review articles are welcome but should be topical and not just an overview of the literature. Review articles should not exceed 5,000 words in …Length not stated
- short communicationEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …Length not stated
- short communicationsShort Communications: Reports on important new results that fall within the scope of the journal may be submitted as short communications. These papers should n…Length not stated
- viewpointEditorials: Editorials are commissioned for publication by the Editors. Authors who wish to contribute an Editorial to the journal should contact the Editorial …main text ≤ 1,500 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Submission declaration Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics in publishing Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Open access Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Churchill Livingstone
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bi-monthly
- Founded
- 1992
- ISSN
- 0960-9776
- Electronic ISSN
- 1532-3080
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about BREAST
What CAS zone is BREAST in?
In the 2025 upgraded edition of the CAS Journal Ranking, BREAST is in Zone 2 of Medicine, and in Zone 2 of the minor category Obstetrics & Gynecology / Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of BREAST?
The latest impact factor listed by LetPub is 5.05; CiteScore 12.6, h-index 129.
How long does peer review take at BREAST?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 111 days (interquartile range 69–167 days); authors report an average review time of about 1 month; the community-reported acceptance is “12%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of BREAST?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Highlights: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of BREAST based?
Of the 63 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (10), France (8) and Belgium (7). Counted from the institutions listed on the board page; for reference only.
Which databases index BREAST?
According to LetPub and DOAJ records, BREAST is indexed in SCIE, Scopus and DOAJ.
Is BREAST open access, and what is the APC?
BREAST is a fully open-access journal. APC about USD 3,200.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .